• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

结直肠癌患者治疗开始1年后自我报告的经济困难情况。

Self-reported financial difficulties of colorectal cancer patients 1 year after start of treatment.

作者信息

Sibert N T, Breidenbach C, Benz S R, Post S, Seufferlein T, Ackermann C, Blossey R D, Böhm G, Brennfleck F, Bunse J, Dahlke M-H, Egetemeyer J, Elhabash S, Emmanouilidis N, Flemming S, Freitag B, Goetzky K, von Haeften E, Henschel M, Hollerbach S, Höppner J, Kim M, Klein C, Klinik C, Klump B, Köninger J, Lee L D-G, Mirow L, Ockenga J, Petzoldt S, Neumann P A, Piso P, Reißfelder C, Rickenberger A, Riechmann M, Rolinger J, Rosenberg R, Schilawa D, Schmidt J, Schnell M W, Steinemann D, Varga-Szabó D, Wahba R, Weyhe D, Willeke F, Wirth U, Wittel U, Zielinski C B, Kolb V, Kowalski C

机构信息

Department of Health Services Research, German Cancer Society, Berlin, Germany; Oncological Health Services Research with a Focus on Digital Medicine, Department of Gynaecology and Obstetrics, CIO Aachen, Düsseldorf, Germany; University Hospital Düsseldorf, Heinrich-Heine University Düsseldorf, Düsseldorf, Germany.

Department of Health Services Research, German Cancer Society, Berlin, Germany.

出版信息

ESMO Open. 2025 May;10(5):105078. doi: 10.1016/j.esmoop.2025.105078. Epub 2025 May 2.

DOI:10.1016/j.esmoop.2025.105078
PMID:40318268
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC12123340/
Abstract

BACKGROUND

The purpose of this study is to investigate self-reported financial difficulties (FDs) in patients with colorectal cancer (CRC) and to develop easy-to-implement models to predict FDs 1 year after initiation of CRC treatment.

MATERIALS AND METHODS

In the prospective EDIUM cohort, CRC patients are asked to complete the European Organisation for Research and Treatment of Cancer (EORTC) Quality of Life Questionnaire Core 30 (QLQ-C30) and QLQ-CR29 before (T0) and 1 year after initiation of treatment (T1). These patient-reported outcomes are combined with sociodemographic and clinical data. The QLQ-C30 'FD' item is firstly analysed descriptively, together with covariates. Logistic lasso regression was carried out to develop a predictive model (full model) of FDs at T1, and its predictive capacity was assessed. This predictive model was then simplified using easy-to-collect predictors which showed importance in the full model.

RESULTS

Of 9124 CRC patients enrolled between October 2018 and May 2023, 6061 completed follow-up questionnaires (T1). Of those initially without FDs (n = 4989), 25% (1248 patients) reported new FDs at T1. These patients were younger [median age 66 versus 72 years; odds ratio (OR) 2.81 (95% confidence interval [CI] 2.46-3.22)] and had a higher proportion of lower educational attainment [74% versus 69%; OR 1.32 (95% CI 1.14-1.54)]. Clinically, FDs were more frequently reported by patients with higher International Union Against Cancer (UICC) stages [48% in stages III/IV versus 32.5% in stages I/II; OR 1.98 (95% CI 1.74-2.26)] and rectal cancer [37% versus 28%; OR 1.52 (95% CI 1.32-1.73)]. The full model [based on a test and training dataset of n = 5910 patients, including 14 predictors, area under the curve (AUC) 0.75] was reduced to two simplified models with only the predictors age, sex (model 1, AUC 0.72)/localisation of tumour (model 2), and FDs at T0 (AUC = 0.74). On this basis, two risk assessment tables were developed.

CONCLUSIONS

A significant proportion of CRC patients report FDs 1 year after treatment initiation, particularly among socioeconomically disadvantaged groups. Together with the predictive models and two ready-to-use risk assessment tables, these findings can be utilised by clinicians and psychosocial counselling services to provide tailored support options.

摘要

背景

本研究旨在调查结直肠癌(CRC)患者自我报告的经济困难(FDs)情况,并开发易于实施的模型来预测CRC治疗开始1年后的FDs。

材料与方法

在前瞻性EDIUM队列中,CRC患者被要求在治疗开始前(T0)和治疗开始1年后(T1)完成欧洲癌症研究与治疗组织(EORTC)生活质量问卷核心30(QLQ-C30)和QLQ-CR29。这些患者报告的结果与社会人口统计学和临床数据相结合。首先对QLQ-C30的“FD”项目进行描述性分析,并结合协变量。进行逻辑套索回归以建立T1期FDs的预测模型(完整模型),并评估其预测能力。然后使用在完整模型中显示出重要性的易于收集的预测因子对该预测模型进行简化。

结果

在2018年10月至2023年5月期间纳入的9124例CRC患者中,6061例完成了随访问卷(T1)。在最初没有FDs的患者(n = 4989)中,25%(1248例患者)在T1期报告了新的FDs。这些患者更年轻[中位年龄66岁对72岁;优势比(OR)2.81(95%置信区间[CI] 2.46 - 3.22)],且教育程度较低的比例更高[74%对69%;OR 1.32(95% CI 1.14 - 1.54)]。临床上,国际抗癌联盟(UICC)分期较高的患者[III/IV期为48%,I/II期为32.5%;OR 1.98(95% CI 1.74 - 2.26)]和直肠癌患者[37%对28%;OR 1.52(95% CI 1.32 - 1.73)]更常报告FDs。完整模型[基于n = 5910例患者的测试和训练数据集,包括14个预测因子,曲线下面积(AUC)0.75]简化为两个简化模型,仅包含预测因子年龄、性别(模型1,AUC 0.72)/肿瘤部位(模型2)以及T0期的FDs(AUC = 0.74)。在此基础上,制定了两个风险评估表。

结论

相当一部分CRC患者在治疗开始1年后报告有FDs,尤其是在社会经济弱势群体中。连同预测模型和两个现成的风险评估表,临床医生和心理社会咨询服务机构可利用这些发现提供量身定制的支持方案。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9c28/12123340/999c59c09296/gr3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9c28/12123340/c2cbcccec9dd/gr1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9c28/12123340/df79ed1708ec/gr2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9c28/12123340/999c59c09296/gr3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9c28/12123340/c2cbcccec9dd/gr1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9c28/12123340/df79ed1708ec/gr2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9c28/12123340/999c59c09296/gr3.jpg

相似文献

1
Self-reported financial difficulties of colorectal cancer patients 1 year after start of treatment.结直肠癌患者治疗开始1年后自我报告的经济困难情况。
ESMO Open. 2025 May;10(5):105078. doi: 10.1016/j.esmoop.2025.105078. Epub 2025 May 2.
2
Health-related quality of life in patients with microsatellite instability-high or mismatch repair deficient metastatic colorectal cancer treated with first-line pembrolizumab versus chemotherapy (KEYNOTE-177): an open-label, randomised, phase 3 trial.微卫星不稳定高或错配修复缺陷转移性结直肠癌患者一线帕博利珠单抗与化疗治疗的健康相关生活质量(KEYNOTE-177):一项开放标签、随机、III 期试验。
Lancet Oncol. 2021 May;22(5):665-677. doi: 10.1016/S1470-2045(21)00064-4. Epub 2021 Apr 1.
3
A large scale prospective clinical and psychometric validation of the EORTC colorectal (QLQ-CR29) module in Polish patients with colorectal cancer.欧洲癌症研究与治疗组织结直肠癌(QLQ-CR29)模块在波兰结直肠癌患者中的大规模前瞻性临床和心理测量学验证。
Eur J Cancer Care (Engl). 2017 Nov;26(6). doi: 10.1111/ecc.12713. Epub 2017 May 11.
4
Pain and overall quality of life in palliatively treated colorectal cancer patients 1 year after diagnosis- results from the EDIUM cohort.姑息治疗的结直肠癌患者诊断后1年的疼痛及总体生活质量——来自EDIUM队列研究的结果
J Cancer Res Clin Oncol. 2025 Mar 31;151(4):127. doi: 10.1007/s00432-025-06186-x.
5
Validation of the chinese version of the EORTC QLQ-CR29 in patients with colorectal cancer.欧洲癌症研究与治疗组织核心生活质量问卷CR29中文版在结直肠癌患者中的效度验证
World J Gastroenterol. 2017 Mar 14;23(10):1891-1898. doi: 10.3748/wjg.v23.i10.1891.
6
Mapping EORTC-QLQ-C30 and QLQ-CR29 onto EQ-5D-5L in Colorectal Cancer Patients.将欧洲癌症研究与治疗组织生活质量问卷核心30项(EORTC-QLQ-C30)和结直肠癌29项问卷(QLQ-CR29)映射到结直肠癌患者的欧洲五维健康量表(EQ-5D-5L)
J Gastrointest Cancer. 2020 Mar;51(1):196-203. doi: 10.1007/s12029-019-00229-6.
7
Predicting SF-6D from the European Organization for Treatment and Research of Cancer Quality of Life Questionnaire scores in patients with colorectal cancer.预测结直肠癌患者欧洲癌症研究与治疗组织生活质量问卷评分的 SF-6D 得分。
Value Health. 2013 Mar-Apr;16(2):373-84. doi: 10.1016/j.jval.2012.12.004.
8
Clinical and psychometric validation of the EORTC QLQ-CR29 questionnaire module to assess health-related quality of life in patients with colorectal cancer.EORTC QLQ-CR29 问卷模块评估结直肠癌患者健康相关生活质量的临床和心理计量学验证。
Eur J Cancer. 2009 Nov;45(17):3017-26. doi: 10.1016/j.ejca.2009.08.014. Epub 2009 Sep 16.
9
Validation of the Taiwan Chinese version of the EORTC QLQ-CR29 to assess quality of life in colorectal cancer patients.验证繁体中文版欧洲癌症研究与治疗组织生活质量问卷核心 29 量表用于评估结直肠癌患者的生活质量。
BMC Cancer. 2018 Apr 2;18(1):353. doi: 10.1186/s12885-018-4312-y.
10
A prospective study to validate the Polish language version of the European Organisation for Research and Treatment of Cancer (EORTC) Colorectal Liver Metastases (QLQ-LMC21) module.一项验证欧洲癌症研究与治疗组织(EORTC)结直肠癌肝转移(QLQ-LMC21)模块波兰语版本的前瞻性研究。
Eur J Oncol Nurs. 2017 Aug;29:148-154. doi: 10.1016/j.ejon.2017.05.006. Epub 2017 May 31.

本文引用的文献

1
Predictive factors for return to work among cancer survivors in Europe: A systematic review.预测欧洲癌症幸存者重返工作岗位的因素:系统评价。
Crit Rev Oncol Hematol. 2024 Aug;200:104422. doi: 10.1016/j.critrevonc.2024.104422. Epub 2024 Jun 17.
2
ESMO expert consensus statements on the screening and management of financial toxicity in patients with cancer.ESMO 专家共识声明:癌症患者的财务毒性筛查与管理
ESMO Open. 2024 May;9(5):102992. doi: 10.1016/j.esmoop.2024.102992. Epub 2024 Apr 15.
3
The socioeconomic impact of cancer on patients and their relatives: Organisation of European Cancer Institutes task force consensus recommendations on conceptual framework, taxonomy, and research directions.
癌症对患者及其亲属的社会经济影响:欧洲癌症研究所组织关于概念框架、分类和研究方向的共识建议。
Lancet Oncol. 2024 Apr;25(4):e152-e163. doi: 10.1016/S1470-2045(23)00636-8.
4
Cancer-associated financial burden in German head and neck cancer patients.德国头颈癌患者的癌症相关经济负担
Front Oncol. 2024 Jan 26;14:1329242. doi: 10.3389/fonc.2024.1329242. eCollection 2024.
5
Minimally important differences for interpreting EORTC QLQ-C30 change scores over time: A synthesis across 21 clinical trials involving nine different cancer types.最小有意义变化值在解读 EORTC QLQ-C30 时间变化评分中的作用:跨越涉及 9 种不同癌症类型的 21 项临床试验的综合研究
Eur J Cancer. 2023 Jul;188:171-182. doi: 10.1016/j.ejca.2023.04.027. Epub 2023 May 7.
6
Outcome Quality After Colorectal Cancer Resection in Certified Colorectal Cancer Centers—Patient-Reported and Short-Term Clinical Outcomes.结直肠癌切除术后的结局质量 - 患者报告和短期临床结局。
Dtsch Arztebl Int. 2022 Dec 2;119(Forthcoming):821-8. doi: 10.3238/arztebl.m2022.0325.
7
Financial difficulties in breast cancer survivors with and without migration background in Germany-results from the prospective multicentre cohort study BRENDA II.德国有和没有移民背景的乳腺癌幸存者的财务困难-前瞻性多中心队列研究 BRENDA II 的结果。
Support Care Cancer. 2022 Aug;30(8):6677-6688. doi: 10.1007/s00520-022-07074-7. Epub 2022 May 4.
8
Financial Impact of Out-of-Pocket Costs Among Patients Undergoing Resection for Colorectal Carcinoma.结直肠癌切除术患者自付费用的经济影响。
Ann Surg Oncol. 2022 Sep;29(9):5387-5397. doi: 10.1245/s10434-022-11755-2. Epub 2022 Apr 16.
9
Cross-sectional study to develop and describe psychometric characteristics of a patient-reported instrument (PROFFIT) for measuring financial toxicity of cancer within a public healthcare system.横断面研究旨在开发和描述一种用于测量公共医疗体系下癌症患者经济毒性的患者报告工具(PROFFIT)的心理计量学特征。
BMJ Open. 2021 Oct 20;11(10):e049128. doi: 10.1136/bmjopen-2021-049128.
10
Patient-Reported Financial Distress in Cancer: A Systematic Review of Risk Factors in Universal Healthcare Systems.癌症患者报告的经济困境:对全民医疗保健系统中风险因素的系统评价。
Cancers (Basel). 2021 Oct 7;13(19):5015. doi: 10.3390/cancers13195015.